Healthcare / Health Information ServicesNasdaqGM
$2.36
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $18.9M · quality 63.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
12/100
F
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$100M
P/E
N/A
•EV/EBITDA
N/A
•ROE
18.1%
↑Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
19.7%
FCF / Net income
2.20x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $120.5M · net income $10.8M · FCF $23.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | $120.5M | $120.5M | $110.8M | $117.1M | $138.8M | $139.6M | $105.1M | $64.4M | $50.5M | $31.8M | — | — | — | — |
| Net Income | $10.8M | $10.8M | $7.9M | $-48.7M | $5.4M | $2.8M | $-8.8M | $-872000.00 | $-2.1M | $-5.6M | $-8.8M | $-4.7M | $-4.5M | $-177996.00 |
| EBITDA | $26.3M | $26.3M | $23.3M | $-32.7M | $18.3M | $15.7M | $1.6M | $3.1M | $314010.00 | $-222217.00 | $-2.8M | $140348.00 | $-1.2M | $821015.00 |
| EPS | 0.10 | 0.10 | -0.28 | -4.11 | -0.67 | -0.77 | — | — | — | — | — | — | -0.64 | -0.03 |
| Operating Margin | 9.4% | 9.4% | 8.2% | -40.2% | 4.8% | 2.5% | -7.9% | 0.1% | -5.0% | -14.2% | — | — | — | — |
| Net Margin | 9.0% | 9.0% | 7.1% | -41.6% | 3.9% | 2.0% | -8.4% | -1.4% | -4.2% | -17.5% | — | — | — | — |
| Balance Sheet | ||||||||||||||
| Debt/Equity | — | — | — | — | — | — | — | — | — | — | 0.57 | 0.32 | 0.00 | — |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $23.8M | $23.8M | $18.9M | $12.4M | $18.6M | $10.4M | $-3.5M | $5.6M | — | — | — | — | — | — |
| Returns | ||||||||||||||
| ROE | 18.1% | 18.1% | 15.8% | -116.7% | 5.3% | 2.9% | -8.7% | -2.0% | -5.5% | -27.5% | -124.5% | -31.5% | -31.5% | -150.2% |
| Growth & Yield | ||||||||||||||
| Revenue Growth | 8.7% | 8.7% | -5.3% | -15.7% | -0.6% | 32.8% | 63.1% | 27.5% | 58.9% | — | — | — | — | — |
| EPS Growth | 135.7% | 135.7% | 93.2% | -513.4% | 13.0% | — | — | — | — | — | — | — | -2033.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
27.9%
EPS terminal req.
$0.21
Spread vs growth
107.8%
5Y implied EPS CAGR
20.4%
EPS terminal req.
$0.25
Spread vs growth
115.3%
10Y implied EPS CAGR
15.1%
EPS terminal req.
$0.41
Spread vs growth
120.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.